Welcome to the New Mexico Chapter of the American College of Cardiology
Welcome to the New Mexico Chapter of the American College of Cardiology
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- ACC, Other CV Societies Urge Withdrawal of OMB Research Funding ProposalThe ACC, joined by the American Society of Echocardiography, the American Society of Nuclear Cardiology, the Society for Cardiovascular Angiography & Interventions, and the Society of Cardiovascular Computed Tomography, has submitted comments to the Office of Management and Budget (OMB) expressing significant concerns with proposed revisions to the Uniform Guidance governing federal financial assistance programs.
- Safety of Antiarrhythmic Agents in Breastfeeding WomenAccording to the American Academy of Pediatrics (APA) and the World Health Organization (WHO), exclusive breastfeeding is recommended for the first 6 months of infant life, with continuation up to 2 years or as long as mutually desired by the lactating individual and infant.
- Novel TEER System Safe, Effective For High-Risk Primary MR PatientsFor high-risk patients with primary mitral valve regurgitation (MR), the novel Neonova transcatheter edge-to-edge repair (TEER) system was safe and effective, with a high rate of event-free survival and sustained clinical and echocardiographic improvements through two years, according to a prospective study published June 29 in JACC: Asia.
- Joint Society Editorial Calls For Science-Based Approach to CV Health EquityA joint editorial on behalf of the ACC, American Heart Association, European Society of Cardiology and World Heart Federation calls for a new era of equity-centered cardiovascular care designed to redefine prevention, optimize care delivery and ensure that all patients worldwide benefit equally from the promise of modern cardiovascular medicine.
- SHaRe Registry Identifies MACE Predictors in Mild HCMAbout one in five patients with phenotypically mild hypertrophic cardiomyopathy (HCM) experienced major adverse cardiovascular events (MACE) over seven years of follow-up, according to SHaRe Registry research published July 8 in JACC.

Please join our cardiology colleagues at the ACC Annual Meeting, a premier gathering of cardiovascular professionals from around the world. This dynamic conference brings together leading physicians, researchers, healthcare innovators, and industry experts to explore the latest advances in cardiovascular medicine. Attendees will experience cutting-edge clinical education, groundbreaking research presentations, interactive learning sessions, and exceptional networking opportunities focused on improving patient care and advancing the future of heart health.